Drug
Bupropion Hydrochloride (xl)
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Product Substitution Issue | 282 | 37.7 | 41.9 | signal |
| 2 | Cardiogenic Shock | 36 | 19.4 | 19.6 | signal |
| 3 | Status Epilepticus | 22 | 14.9 | 15.0 | signal |
| 4 | Generalised Tonic-clonic Seizure | 30 | 14.1 | 14.2 | signal |
| 5 | Coeliac Disease | 17 | 13.3 | 13.4 | signal |
| 6 | Product Odour Abnormal | 15 | 11.1 | 11.1 | signal |
| 7 | Insurance Issue | 20 | 10.3 | 10.4 | signal |
| 8 | Completed Suicide | 111 | 10.1 | 10.5 | signal |
| 9 | Intentional Overdose | 81 | 9.7 | 10.0 | signal |
| 10 | Crying | 42 | 8.8 | 9.0 | signal |
| 11 | Serotonin Syndrome | 21 | 8.4 | 8.5 | signal |
| 12 | Cardio-respiratory Arrest | 45 | 8.2 | 8.3 | signal |
| 13 | Ventricular Tachycardia | 17 | 7.9 | 7.9 | signal |
| 14 | Immunodeficiency | 15 | 7.8 | 7.8 | signal |
| 15 | Suicidal Ideation | 92 | 7.7 | 7.9 | signal |
| 16 | Euphoric Mood | 10 | 7.4 | 7.5 | signal |
| 17 | Middle Insomnia | 18 | 7.4 | 7.5 | signal |
| 18 | Myoclonus | 11 | 7.1 | 7.1 | signal |
| 19 | Inability To Afford Medication | 9 | 7.0 | 7.0 | signal |
| 20 | Tinnitus | 42 | 7.0 | 7.1 | signal |
| 21 | Suicide Attempt | 52 | 6.6 | 6.7 | signal |
| 22 | Sinus Tachycardia | 12 | 6.5 | 6.5 | signal |
| 23 | Brain Fog | 12 | 6.3 | 6.3 | signal |
| 24 | Depression | 187 | 6.3 | 6.7 | signal |
| 25 | Electrocardiogram Qt Prolonged | 29 | 6.2 | 6.2 | signal |
| 26 | Intentional Dose Omission | 22 | 6.2 | 6.2 | signal |
| 27 | Irritability | 48 | 6.1 | 6.2 | signal |
| 28 | Mental Status Changes | 22 | 6.1 | 6.1 | signal |
| 29 | Feeling Jittery | 15 | 6.0 | 6.0 | signal |
| 30 | Infusion Site Pain | 10 | 6.0 | 6.0 | signal |
| 31 | Seasonal Allergy | 11 | 6.0 | 6.0 | signal |
| 32 | Withdrawal Syndrome | 32 | 5.8 | 5.9 | signal |
| 33 | Panic Attack | 27 | 5.7 | 5.7 | signal |
| 34 | Economic Problem | 11 | 5.5 | 5.5 | signal |
| 35 | Impaired Gastric Emptying | 9 | 5.4 | 5.4 | signal |
| 36 | Impaired Quality Of Life | 10 | 5.3 | 5.3 | signal |
| 37 | Disease Recurrence | 33 | 5.3 | 5.4 | signal |
| 38 | Initial Insomnia | 7 | 5.3 | 5.3 | signal |
| 39 | Product Quality Issue | 91 | 5.2 | 5.3 | signal |
| 40 | Mania | 11 | 5.1 | 5.1 | signal |
| 41 | Disturbance In Attention | 36 | 5.1 | 5.2 | signal |
| 42 | Seizure | 76 | 5.1 | 5.2 | signal |
| 43 | Encephalopathy | 16 | 5.0 | 5.0 | signal |
| 44 | Anger | 22 | 5.0 | 5.0 | signal |
| 45 | Thinking Abnormal | 12 | 4.9 | 4.9 | signal |
| 46 | Mood Swings | 20 | 4.8 | 4.8 | signal |
| 47 | Mydriasis | 8 | 4.8 | 4.8 | signal |
| 48 | Surgery | 36 | 4.8 | 4.8 | signal |
| 49 | Prescribed Overdose | 12 | 4.8 | 4.8 | signal |
| 50 | Apathy | 9 | 4.7 | 4.8 | signal |
| 51 | Bursitis | 7 | 4.4 | 4.5 | signal |
| 52 | Spinal Operation | 7 | 4.4 | 4.4 | signal |
| 53 | Agitation | 42 | 4.4 | 4.4 | signal |
| 54 | Anxiety | 160 | 4.3 | 4.5 | signal |
| 55 | Product Physical Issue | 11 | 4.2 | 4.2 | signal |
| 56 | Hypokinesia | 8 | 4.2 | 4.2 | signal |
| 57 | Psychomotor Hyperactivity | 9 | 4.1 | 4.1 | signal |
| 58 | Anhedonia | 14 | 4.1 | 4.1 | signal |
| 59 | Impaired Driving Ability | 6 | 4.0 | 4.0 | signal |
| 60 | Hallucination, Visual | 11 | 4.0 | 4.0 | signal |
| 61 | Pharyngeal Swelling | 5 | 4.0 | 4.0 | signal |
| 62 | Hunger | 7 | 4.0 | 4.0 | signal |
| 63 | Therapy Change | 5 | 4.0 | 4.0 | signal |
| 64 | Knee Operation | 5 | 3.9 | 4.0 | signal |
| 65 | Impaired Work Ability | 11 | 3.9 | 3.9 | signal |
| 66 | Embedded Device | 5 | 3.9 | 3.9 | signal |
| 67 | Unresponsive To Stimuli | 13 | 3.9 | 3.9 | signal |
| 68 | Hypotonia | 5 | 3.8 | 3.8 | signal |
| 69 | Drug Effect Less Than Expected | 7 | 3.8 | 3.8 | signal |
| 70 | Nocturia | 6 | 3.8 | 3.8 | signal |
| 71 | Depressed Mood | 26 | 3.8 | 3.8 | signal |
| 72 | Poor Quality Product Administered | 5 | 3.7 | 3.8 | signal |
| 73 | Product Dose Omission In Error | 13 | 3.7 | 3.7 | signal |
| 74 | Mood Altered | 13 | 3.7 | 3.7 | signal |
| 75 | Intentional Product Use Issue | 42 | 3.7 | 3.7 | signal |
| 76 | Complication Of Device Removal | 8 | 3.6 | 3.6 | signal |
| 77 | Adverse Drug Reaction | 42 | 3.6 | 3.6 | signal |
| 78 | Poor Quality Sleep | 10 | 3.6 | 3.6 | signal |
| 79 | Rotator Cuff Syndrome | 6 | 3.6 | 3.6 | signal |
| 80 | Back Injury | 5 | 3.5 | 3.5 | signal |
| 81 | Laryngitis | 5 | 3.5 | 3.5 | signal |
| 82 | Cardiac Arrest | 38 | 3.5 | 3.6 | signal |
| 83 | Bedridden | 6 | 3.5 | 3.5 | signal |
| 84 | Dental Caries | 5 | 3.5 | 3.5 | signal |
| 85 | Adverse Reaction | 6 | 3.5 | 3.5 | signal |
| 86 | Hyperhidrosis | 58 | 3.4 | 3.5 | signal |
| 87 | Sinus Congestion | 6 | 3.4 | 3.4 | signal |
| 88 | Restless Legs Syndrome | 8 | 3.4 | 3.4 | signal |
| 89 | Illness | 44 | 3.4 | 3.4 | signal |
| 90 | Covid-19 | 77 | 3.3 | 3.4 | signal |
| 91 | Migraine | 41 | 3.3 | 3.3 | signal |
| 92 | Abnormal Dreams | 12 | 3.3 | 3.3 | signal |
| 93 | Knee Arthroplasty | 9 | 3.3 | 3.3 | signal |
| 94 | Nightmare | 15 | 3.3 | 3.3 | signal |
| 95 | Contraindicated Product Administered | 13 | 3.3 | 3.3 | signal |
| 96 | Affect Lability | 4 | 3.2 | 3.2 | no signal |
| 97 | Decreased Immune Responsiveness | 4 | 3.1 | 3.1 | no signal |
| 98 | Libido Decreased | 5 | 3.1 | 3.1 | signal |
| 99 | Salivary Hypersecretion | 4 | 3.1 | 3.1 | no signal |
| 100 | Feeling Abnormal | 96 | 3.1 | 3.1 | signal |
| 101 | Poisoning | 5 | 3.0 | 3.0 | signal |
| 102 | Hypothermia | 4 | 3.0 | 3.0 | no signal |
| 103 | Dry Throat | 4 | 3.0 | 3.0 | no signal |
| 104 | Psychotic Disorder | 11 | 2.9 | 2.9 | signal |
| 105 | Product Taste Abnormal | 5 | 2.8 | 2.9 | signal |
| 106 | Intentional Product Misuse | 32 | 2.8 | 2.8 | signal |
| 107 | Device Occlusion | 5 | 2.8 | 2.8 | no signal |
| 108 | Toxicity To Various Agents | 60 | 2.7 | 2.8 | signal |
| 109 | Disability | 7 | 2.7 | 2.7 | signal |
| 110 | Abnormal Behaviour | 14 | 2.7 | 2.7 | signal |
| 111 | Bone Density Decreased | 11 | 2.7 | 2.7 | signal |
| 112 | Paranoia | 6 | 2.7 | 2.7 | signal |
| 113 | Overdose | 71 | 2.5 | 2.6 | signal |
| 114 | Nerve Compression | 3 | 2.5 | 2.5 | no signal |
| 115 | Blood Thyroid Stimulating Hormone Increased | 3 | 2.5 | 2.5 | no signal |
| 116 | Nervousness | 17 | 2.5 | 2.5 | signal |
| 117 | Emotional Disorder | 10 | 2.5 | 2.5 | signal |
| 118 | Dermatitis Atopic | 16 | 2.5 | 2.5 | signal |
| 119 | Unevaluable Event | 24 | 2.4 | 2.4 | signal |
| 120 | Laceration | 3 | 2.4 | 2.4 | no signal |
| 121 | Product Availability Issue | 7 | 2.4 | 2.4 | signal |
| 122 | Therapeutic Response Unexpected | 14 | 2.4 | 2.4 | signal |
| 123 | Sleep Disorder Due To A General Medical Condition | 5 | 2.4 | 2.4 | no signal |
| 124 | Hair Texture Abnormal | 4 | 2.3 | 2.3 | no signal |
| 125 | Hereditary Angioedema | 3 | 2.2 | 2.2 | no signal |
| 126 | Pelvic Pain | 5 | 2.1 | 2.1 | no signal |
| 127 | Bipolar Disorder | 3 | 2.1 | 2.1 | no signal |
| 128 | Sedation | 7 | 2.1 | 2.1 | no signal |
| 129 | Exposure Via Skin Contact | 6 | 2.0 | 2.0 | no signal |
| 130 | Exposure During Pregnancy | 16 | 2.0 | 2.0 | no signal |
| 131 | Hallucination, Auditory | 4 | 1.9 | 1.9 | no signal |
| 132 | Psoriasis | 32 | 1.9 | 1.9 | no signal |
| 133 | Needle Issue | 7 | 1.9 | 1.9 | no signal |
| 134 | Multiple Fractures | 4 | 1.8 | 1.9 | no signal |
| 135 | Tooth Loss | 5 | 1.8 | 1.8 | no signal |
| 136 | Hair Colour Changes | 3 | 1.8 | 1.8 | no signal |
| 137 | Dysmenorrhoea | 3 | 1.8 | 1.8 | no signal |
| 138 | Device Breakage | 9 | 1.8 | 1.8 | no signal |
| 139 | Menstruation Irregular | 6 | 1.7 | 1.7 | no signal |
| 140 | Psoriatic Arthropathy | 9 | 1.7 | 1.7 | no signal |
| 141 | Therapeutic Response Shortened | 7 | 1.7 | 1.7 | no signal |
| 142 | Product Dose Omission | 14 | 1.6 | 1.6 | no signal |
| 143 | Intentional Self-injury | 4 | 1.5 | 1.5 | no signal |
| 144 | Emotional Distress | 24 | 1.5 | 1.5 | no signal |
| 145 | Product Dispensing Error | 4 | 1.4 | 1.4 | no signal |
| 146 | Drug Withdrawal Syndrome | 16 | 1.4 | 1.4 | no signal |
| 147 | Extra Dose Administered | 7 | 1.3 | 1.3 | no signal |
| 148 | Drug Effect Decreased | 9 | 1.3 | 1.3 | no signal |
| 149 | Device Dislocation | 7 | 1.2 | 1.2 | no signal |
| 150 | Product Complaint | 4 | 1.2 | 1.2 | no signal |
| 151 | Drug Abuse | 13 | 1.2 | 1.2 | no signal |
| 152 | Dystonia | 3 | 1.2 | 1.2 | no signal |
| 153 | Application Site Erythema | 4 | 1.2 | 1.2 | no signal |
| 154 | Multiple Sclerosis | 7 | 1.1 | 1.1 | no signal |
| 155 | Injection Site Rash | 4 | 1.0 | 1.0 | no signal |
| 156 | Accidental Exposure To Product | 13 | 1.0 | 1.0 | no signal |
| 157 | Device Leakage | 5 | 0.9 | 0.9 | no signal |
| 158 | Tardive Dyskinesia | 3 | 0.8 | 0.8 | no signal |
| 159 | Device Malfunction | 7 | 0.8 | 0.8 | no signal |
| 160 | Product Adhesion Issue | 3 | 0.6 | 0.6 | no signal |
| 161 | Drug Dependence | 8 | 0.4 | 0.4 | no signal |